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Abstract
Brucellosis is an infectious disease that affects
domestic animals, producing heavily losses
through abortions, and infertility in rams.The
flock epidemiology situation in the north
Patagonic area ofArgentina (La Pampa) to the
present disease is unknown; consequently the
objective was to determine the prevalence of
the disease. Out of 10.000 sheep, there were
sampled 1.800 animals according to the appli-
cation of the minimum sample size for esti-
mating a rate with specified degree of
precision in the Departments of Mara-co,
Chapaleufu, Realico, Rancul, Conhelo and
Quemu-Quemu representing an area of
22.072 km2, in the frame of reintroduction of
sheep production in the province. Indepen-
dently of the number of sheep per farm, 20-
30% of the flock was sampled, that represent
15% (270) rams and 85% (1.530) ewes.After
collecting serum from jugular blood, the sam-
ples were analysed either for the presence of
antibodies against smooth strain through
Buffer Plate Agglutination Test (BPA); or anti-
bodies against rough strain of brucella through
Agar Gel Immuno-diffusion Test (AGID). Be-
wilderment of all the animals was negative to
both tests.Despite brucellosis is a high preva-
lent infectious di-sease in other part of the
country, these results emphasise the condition
of free areas of the disease.
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Introduction
Brucelosis is an infectious disease of high eco-
nomic impact affecting several animal species,
particularly those of economic interest such
as bovine and ovine (Samartino, 2002). The
World Organisation for Animal Health (OIE)
considers the disease as a treat of public
health, and a boundary for international trade
of animals (OIE, 2004). Brucelosis is caused by
a GRAM (-) bacteria, classified by antigenic dif-
ferences and host specificity in: Brucella ovis
(ovine), Brucella canis (canines), Brucella suis
(porcine), Brucella abortus (bovines) and Bru-
cella melitensis (ovine and caprine). In humans
the infections are basically produced by Bru-
cella abortus or melitensis which show that
host specificity is not strict (Young, 1995;Wal-
lach et al., 1998,World Health Organization,
2008). In Argentina the disease is high preva-
lent in bovines, around 4-5% (Samartino,2002),
but there is not precise data that document
the epidemiology situation of the disease in
ovine. Brucella melitensis, and ovis in less pro-
portion, are the more common subtypes
found in sheep-rearing countries (Garin-Bas-
tuji et al., 1998; Minas et al., 2004). Local data
from Patagonia and Buenos Aires province,
show the presence of Brucella ovis infection,
represented by infertility in rams and abortus
in sheep (Alton et al., 1988;Robles et al., 1998;
Lopez et al., 2005).
It is well known the laborious situation to con-
trol and eradicate brucelosis from beef cattle,
despite the execution of actions such as com-
pulsory vaccination from 3 to 8 months female
calf, and segregation of adult positive animals.
Those actions, certainly effective, are taken
without any concern about the bacteriologi-
cal situation of the ovine flock (potential host
of Brucella abortus subtype), that usually share
paddocks with cattle.Consequently, it is highly
relevant to generate basic information about
the current bacteriological situation of La
Pampa ovine flock. In the frame of the national
ovine law, where the sheep industry is reco-
vering through precise actions taken by the
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Ninf = P (1-P) Z2
d2
P = the estimated prevalence of infection (as a decimal)
Z = corresponds to the degree of confidence in our estimate (usually Z = 1.96 for 95% con-
fidence in our estimate)
d = the maximun difference between observed and true prevalence that we are willing to ac-
cept (as a decimal)
Blood samples
Glass tubes without additives were used for
sampling of serum, which were analysed for
presence of antibodies against both smooth
and rough strains of Brucella.The tubes were
centrifuged at 2000 g for 15 minutes to obtain
serum, which were frozen at -20 ºC until
analyses.
Antibodies detection
All serum samples were analysed for the pres-
ence of antibodies against the smooth strain of
Brucella spp. through the Buffer Plate Aggluti-
nation Test (BPA) (potential positives to Bru-
cella melitensis and abortus). Eighty µl of
serum and 30 µl of antigen (B.P.A.
Agropharma,Argentina) were mixed in a 3 x 3
cm2 glass plaque during 8 minutes and any sign
of agglutination was considered positive there-
after Angus and Burton, 1984; Alton et al.,
1988).
Agar gel inmunodifusion test (AGID) was used
to determine the presence of serum antibo-
dies against the rough strain of Brucella ovis.
The gel was prepared dissolving 1,2 g of noble
agar, 8.5 g of NaCl and merthiolate 1:10.000 in
100 ml of distilled water pH 8,2, in a boiling
water bath. A plaque was covered with ap-
proximately 15 ml of melted gel, and then it
was solidified, a hole was cut using a gel
puncher.The hole was 3 mm in diameter and
3 mm apart, organised in a hexagonal pattern
around a central hole, also 3 mm in diameter.
Control and test sera were placed in wells
with the antigen in the central well.The result
was read after the incubation at room tem-
perature during 48 hours in a humid chamber
(Lopez et al., 2005).The antigen, precipitates
with positive sera of rough strain of Brucella,
was supplied by SENASA (National Animal
Health Service)Argentina,which also provides
the control standard serum.
Five percent of the AGID negative samples
were sent to a referent laboratory (Laborato-
rio Central, INTA Castelar, Buenos Aires,Ar-
gentina) to be analysed for Complement
local and national governments, it is important
to originate information to favour the pro-
ductive process and to generate knowledge of
the epidemiology status of the disease.There-
fore, the main objective of the project was to
determine the prevalence of the disease in the
ovine flock in the north of La Pampa province.
Methods
Animals and size of the sample
Adult Merino and Corriedale sheep (ewes and
rams), belonging to flocks registered in La
Pampa Ovine Plan,were blood sampled during
a period of six months. At the initial time of
the project, 10.000 sheep were distributed in
300 farms at the Departments of Mara-co,
Chapaleufu, Realico, Rancul, Conhelo and
Quemu-Quemu, representing an area of
22.072 km2, at the north of La Pampa
province. Independently of the farm flock size,
20-30% of animals were sampled, and the total
number to be sampled for the project (n) was
estimated by the equation suggested by Smith
(1995) with specified degree of freedom.As it
was not known the historic record of preva-
lence of ovine brucelosis in the province, we
suggested a 5% prevalence, taken as reference
the province bovine information of the dis-
ease, so that, and applying the equation sited
by Smith, the number of animals to be sam-
pled was 1.800.
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fixation and ELISA in order to corroborate
the AGID results.
Results
Out of 1.800 sampled, 270 represented rams
(15%) and 1.530 ewes (85%).All 1.800 serum
sampled were negative to the presence of an-
tibodies at both tests,BPA andAGID.Fifty per-
cent of the rams (135) were clinically palpated,
to detect genital abnormality at the time of
blood sampling, but none of them were diag-
nosed with any lesion. Despite it is an unspe-
cific diagnosis, in the present trial correlates
positively with the antibodies tests.
Discussion
In many areas of Argentina, and in contrast to
other sheep-rearing countries such as Spain
or Italy, the predominant strain of infection is
Brucella ovis (Robles et al., 1998; Lopez et al.,
2005), which has many advantages in control
and eradication programmes to Brucella
melitensis infections.The ovis strain of Bru-
cella lacks the lipopolissacaride responsible for
the exacerbated virulence, and it has high host
specificity restricted to the ovine population,
relevant characteristics that make this bac-
terium feasible to control and eradicate
(Marin et al., 1989).
The north-patagonic flock, with especial ref-
erence to La Pampa, has developed consider-
able during the last five years. The farmers,
taking the governmental benefit, bought sheep
without considering the health status as a pri-
ority, nevertheless and bewilderment of the
results, the presence of the disease in the de-
fined area is nil.
Different laboratories suggest the AGID test
as a subjective assay, and are replaced by more
sensitive and objective test such as enzime
linked inmunoabsorband assay (ELISA).On the
other hand, theWorld Organization for Ani-
mal Health ensures that the sensitibity of the
AGID is similar to the ELISA test, and because
of the low cost and simplicity it is still the rec-
ommended technique for Brucella ovis diag-
nose (Young, 1995).With a reduced number
of samples (5%), we compared AGID with
Complement Fixation and ELISA test (data
not showed).All the negative samples toAGID
were also negative to Complement Fixation,
and just 7% were positive to ELISA with the
optic density value at the limit of the cut point,
suggested as a false positive reaction.
Conclusions
Despite the high increased in the number of
sheep in the north patagonic area of La Pampa,
the activity of brucelosis in the flock was nil.
The epidemiology situation of the disease is
relevant, and at the same time caution must
be taken by the animal health authorities and
farmers in order to avoid the introduction of
the disease in the defined area.
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